Literature DB >> 17607782

Proteasomal degradation of core protein variants from chronic hepatitis B patients.

Sabine Braun1, Anna Zajakina, Jekaterina Aleksejeva, Anatoly Sharipo, Ruta Bruvere, Velta Ose, Paul Pumpens, Henrik Garoff, Helga Meisel, Tatyana Kozlovska.   

Abstract

The accumulation of complex hepatitis B virus (HBV) variants with internal in-frame deletions in the C gene in immunosuppressed renal transplant recipients is associated with a severe course of the infection leading to end-stage liver disease (ESLD). A set of six HBV C genes with internal in-frame deletions corresponding to the pattern of HBV population in immunosuppressed patients has been expressed in two different eukaryotic cell lines. Synthesis and proteasomal degradation of HBV core (HBc) protein variants were compared with those of the wild-type HBc. In all cases, the steady-state level of internally deleted HBc proteins, predominantly with longer deletions, were considerably lower and turnover was significantly higher in comparison with those of the wild-type HBc, since all deletion variants were degraded rapidly via the proteasome pathway. Involvement and consequences of the proteasomal degradation machinery in the HBc protein turnover during HBV infection with complex HBV variants in the immunosuppressed patients are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607782     DOI: 10.1002/jmv.20939

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Proteasomes regulate hepatitis B virus replication by degradation of viral core-related proteins in a two-step manner.

Authors:  Zi-Hua Zheng; Hui-Ying Yang; Lin Gu; Xiao-Mou Peng
Journal:  Virus Genes       Date:  2016-04-22       Impact factor: 2.332

2.  Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.

Authors:  Arnis Strods; Velta Ose; Janis Bogans; Indulis Cielens; Gints Kalnins; Ilze Radovica; Andris Kazaks; Paul Pumpens; Regina Renhofa
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

Review 3.  The interaction of hepatitis B virus with the ubiquitin proteasome system in viral replication and associated pathogenesis.

Authors:  Fanyun Kong; Hongjuan You; Delong Kong; Kuiyang Zheng; Renxian Tang
Journal:  Virol J       Date:  2019-05-30       Impact factor: 4.099

4.  Design and Synthesis of Hepatitis B Virus (HBV) Capsid Assembly Modulators and Evaluation of Their Activity in Mammalian Cell Model.

Authors:  Karina Spunde; Brigita Vigante; Unda Nelda Dubova; Anda Sipola; Irena Timofejeva; Anna Zajakina; Juris Jansons; Aiva Plotniece; Karlis Pajuste; Arkadij Sobolev; Ruslan Muhamadejev; Kristaps Jaudzems; Gunars Duburs; Tatjana Kozlovska
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-22

5.  Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion.

Authors:  Hui Y Yang; Nai Q Zheng; Dong M Li; Lin Gu; Xiao M Peng
Journal:  Virol J       Date:  2014-09-16       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.